Northern Trust Corp Has $19.25 Million Holdings in Integra LifeSciences Holdings Corporation $IART

Northern Trust Corp cut its stake in Integra LifeSciences Holdings Corporation (NASDAQ:IART - Free Report) by 1.9% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 875,223 shares of the life sciences company's stock after selling 17,202 shares during the period. Northern Trust Corp owned 1.13% of Integra LifeSciences worth $19,246,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of IART. CWM LLC raised its stake in shares of Integra LifeSciences by 413.8% in the first quarter. CWM LLC now owns 6,664 shares of the life sciences company's stock worth $147,000 after acquiring an additional 5,367 shares during the last quarter. Teacher Retirement System of Texas bought a new position in shares of Integra LifeSciences in the first quarter worth about $223,000. NorthRock Partners LLC bought a new position in shares of Integra LifeSciences in the fourth quarter worth about $251,000. Wealth Enhancement Advisory Services LLC bought a new position in shares of Integra LifeSciences in the first quarter worth about $251,000. Finally, Natixis Advisors LLC acquired a new stake in shares of Integra LifeSciences during the 1st quarter worth approximately $297,000. 84.78% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Separately, JMP Securities lowered their price target on shares of Integra LifeSciences from $35.00 to $25.00 and set a "market outperform" rating for the company in a research report on Friday, May 9th. Two equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Reduce" and an average target price of $18.43.

Integra LifeSciences Trading Up 2.2%

Shares of NASDAQ:IART traded up $0.34 during trading on Friday, hitting $15.99. 1,201,252 shares of the company's stock were exchanged, compared to its average volume of 1,269,989. The firm has a market cap of $1.25 billion, a P/E ratio of -2.45, a PEG ratio of 0.90 and a beta of 1.20. The firm has a 50-day moving average price of $13.39 and a two-hundred day moving average price of $15.73. The company has a current ratio of 1.23, a quick ratio of 0.73 and a debt-to-equity ratio of 1.18. Integra LifeSciences Holdings Corporation has a 1-year low of $11.06 and a 1-year high of $27.13.

Integra LifeSciences (NASDAQ:IART - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The life sciences company reported $0.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.43 by $0.02. The firm had revenue of $415.61 million during the quarter, compared to analysts' expectations of $395.06 million. Integra LifeSciences had a negative net margin of 30.87% and a positive return on equity of 12.15%. The business's revenue for the quarter was down .6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.63 earnings per share. Integra LifeSciences has set its FY 2025 guidance at 2.190-2.290 EPS. Q3 2025 guidance at 0.400-0.450 EPS. Equities analysts predict that Integra LifeSciences Holdings Corporation will post 2.45 earnings per share for the current year.

Integra LifeSciences Profile

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services.